Jaguar Health Showcases Novel Plant-Based Gastrointestinal Medicines in Latest Corporate Presentation
I'm PortAI, I can summarize articles.
Jaguar Health Inc. presented updates on its plant-based medicines for gastrointestinal disorders, highlighting FDA-approved Mytesi for HIV/AIDS-related diarrhea and Canalevia-CA1 for chemotherapy-induced diarrhea in dogs. The OnTarget study was emphasized as a pioneering trial, with future plans for metastatic breast cancer studies and expanded access. The presentation is available online.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments